Article Details
Retrieved on: 2025-06-07 17:16:34
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
The consensus estimate for Xeris Biopharma's current full-year earnings is ($0.41) per share. Leerink Partnrs also issued estimates for Xeris ...
Article found on: www.defenseworld.net
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here